Below is a selection of recent journal articles and reports which are on overuse in healthcare. If you are looking to answer a specific question please submit a literature search request at the link above. If you would like to be alerted when new content is available here then please sign in and select Follow. You are welcome to leave comments and suggestions below in the comments section.
The Lancet has also published several articles on overuse and underuse called Right Care: Available here
Amin, EE., Ten Cate-Hoek, AJ., Bouman, AC., et al (2018) Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost effectiveness analysis. The Lancet Haematology 5(11):e512-e519. Individually shortened duration of elastic compression therapy was cost effective compared with standard duration elastic compression therapy. Use of an individualised approach to elastic stocking compression therapy for the prevention of post-thrombotic syndrome after deep vein thrombosis could lead to substantial cost savings without loss in health-related quality of life.
Chassin, MR et al. 1987. Does inappropriate use explain geographic variation in the use of healthcare services. JAMA 258(18):2533-7. The authors studied the appropriateness of use of coronary angiography, carotid endarterectomy, and upper gastrointestinal tract endoscopy and its relationship to geographic variations in the rates of use of these procedures. They conclude that differences in appropriateness cannot explain geographic variations in the use of these procedures.
Diao D, Wright JM, Cundiff DK, Gueyffier F. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev 2012;(8):CD006742. Authors’ conclusions: “Antihypertensive drugs used in the treatment of adults (primary prevention) with mild hypertension (systolic BP 140-159 mmHg and/or diastolic BP 90-99 mmHg) have not been shown to reduce mortality or morbidity in RCTs. Treatment caused 9% of patients to discontinue treatment due to adverse effects. More RCTs are needed in this prevalent population to know whether the benefits of treatment exceed the harms.”
Thorlund, JB., Juhl, CB., Roos, EM., et al. Anthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms. BMJ 2015;350:h2747. “The small inconsequential benefit seen from interventions that include arthroscopy for the degenerative knee is limited in time and absent at one to two years after surgery. Knee arthroscopy is associated with harms. Taken together, these findings do not support the practise of arthroscopic surgery for middle aged or older patients with knee pain with or without signs of osteoarthritis.”